Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion.
Postoperative chylothorax compromises nutrition, immune function, coagulation, and fluid status. We report rapid short-term suppression of chylothorax by octreotide in an infant after surgery for complex congenital heart disease complicated by lymphangiectasia.
Tibballs
James
J
Intensive Care Unit, Royal Children's Hospital, Melbourne, Australia. james.tibballs@rch.org.au
Soto
Rodrigo
R
Bharucha
Tara
T
D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D004322:Drainage; D006330:Heart Defects, Congenital / Q000601:surgery; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008200:Lymphangiectasis / Q000150:complications / Q000151:congenital*; D015282:Octreotide / Q000008:administration & dosage*; D011183:Postoperative Complications
D015282:Octreotide